Metraipolis › archive › dc_a44d26eeab7d

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells — Europe PMC PMID:42308036

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42308036
DOI
10.1073/pnas.2601563123
License (as archived)
solo-consultazione
Archived
2026-10-19T08:58:50.946Z
SHA-256 of the archived text
c8d3b47717768b0efb738fb10deff4efba7db0630b48dce63f5a50a7b9bdd778
Stable URL of this page
https://metraipolis.com/documento/dc_a44d26eeab7d

How to cite

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells — Europe PMC PMID:42308036 — Europe PMC (en), https://europepmc.org/article/MED/42308036 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a44d26eeab7d (Metraipolis archive dc_a44d26eeab7d, sha256 c8d3b47717768b0efb738fb10deff4efba7db0630b48dce63f5a50a7b9bdd778)
BibTeX
@misc{dca44d26eeab7d,
  title = {Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells — Europe PMC PMID:42308036},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42308036},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a44d26eeab7d; sha256 c8d3b47717768b0efb738fb10deff4efba7db0630b48dce63f5a50a7b9bdd778},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42308036. Agents can read the archived copy with the MCP tool read_document.